Skip to content

Injection of two different drugs FOR SPINAL ANAESTHESIA IN PLANNED CESAREAN SECTION EITHER by one OR BY two SYRINGE

INTRATHECAL ADMINISTRATION OF FENTANYL WITH HYPERBARIC BUPIVACAINE AS EITHER A MIXTURE OR SEQUENTIALLY IN ELECTIVE CESAREAN SECTION : A RANDOMIZED PROSPECTIVE SINGLE BLIND STUDY - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016698
Enrollment
160
Registered
2018-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Group S: Group S : fentanyl 25 mcg (0.5 mL) followed by hyperbaric bupivacaine (0.5%) 7.5 mg (1.5 mL) by separate syringes Control Intervention1: Group M: Group M : hyperbaric bupivaca

Sponsors

DRSN MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: parturients with singleton pregnancy American Society of Anaesthesiologist ASA I and II physical status Body weight 50-80 kg Height 150-170 cm

Exclusion criteria

Exclusion criteria: Patients having multiple pregnancy Body weight between 50 kg to 90 kg Height 150 cm to 170 cm ASA grade 3 and 4 patients Patients with history of bleeding disorder or patient on anticoagulant Patients with infection at the site of injection Anatomical abnormality at the regional site Intrauterine deaths or known foetal anomaly Preeclampsia Eclampsia Patients on cardiovascular medications any major systemic disease Patients having history of hypersensitivity to fentanyl and LA

Design outcomes

Secondary

MeasureTime frame
Fetal outcome ( APGAR score Side effect of drug Timepoint: 12 hr

Primary

MeasureTime frame
Block characteristics Intraoperative Haemodynamics analgesia Timepoint: 12 HR

Countries

India

Contacts

Public ContactDR CHANDA KHATRI

DR S N MEDICAL COLLEGE JODHPUR

sarita.janweja@gmail.com9829116420

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026